Tag: ECPN

Blue Horseshoe Stocks: Options, Bottom-Plays & More

MarilynJean Interactive, Inc. MJMI

We want to circle back around to a play we tagged for observation last week. MJMI has been making a good deal of progress, showing upward momentum over the past couple of sessions.

Subsequent to our mention of the stock we took note of a .091 low (Friday), and after a couple days on the upswing, MJMI reached a high of .216 yesterday afternoon. It represents a three session-swing amounting to 137%

We’ll want to see the stock maintain support at or above the 50DMA at .16 on any pullbacks in order to remain interested.

Potential Momentum Plays

Each of the following stocks represents the possibility for continued momentum coming into this morning’s sessions. Both closed just a shade under their respective highs-of-day, and will be placed on watch as we cruise through midweek.

CollabRx, Inc. RNVA – We’re no strangers to this stock, which is in the midst of filling a sizable gap on the chart that presently runs from current PPS levels in the mid-to-upper .30’s, on up to around .47.

Yesterday RNVA hit a high of .39 before closing just below at .37. We’re looking for the stock to produce its fourth consecutive session of higher highs and higher lows today.
______

Intermolecular, Inc. IMI – IMI is new to our reports this morning, and qualifies as both a bottom-bouncer as well as a potential momo-play. It also ended up closing with strength, just a hair shy of its daily high yesterday.

It comes less than a week removed from a big PPS dropoff, so we’ll be on the lookout for the stock to continue this rebound and regain some of the ground it has lost over the past week or so.

Tempur Sealy International, Inc. TPX – Options Update

We also want to provide a quick update on the TPX longer-term options idea that we’ve been tracking for over a week now. We were initially interested in the TPX 08/19 $70-80 Calls. The $70’s have since been pushed too deep in the money, but over the past week both the $75’s and $80’s have performed quite well:

$75 Calls – Range: 1.91-4.50 – Max Gain: 135%
$80 Calls – Range: .38-1.35 – Max Gain: 255%

We’ll continue to track these plays leading into their expiration next Friday.

Extended Watchlist:
ECPN, MINE, EEGI, ASPS, PLG, JD

Blue Horseshoe Stocks: SPY Review & More

SPDR S&P 500 ETF (SPY) – Options Recap

We continued to track our successful options idea from earlier in the week yesterday morning, as the SPY Weekly $188-191 Calls once again provided ammunition for some serious gains. Despite already having moved up considerably, we mentioned our expectations that those figures would be pushed higher and indeed they were.

As we did yesterday to save time, we’ll just outline the gains made by the bookend contracts of our observed range; similar gains would have been up for grabs in any of the contracts within. The $188 Calls extended their new high to 5.35, which represents a 226% overall move, and the $191’s  pushed to 2.68- a gain of 587% over Tuesday’s low.

In addition to tracking our initial idea, our trader’s chat participants* were offered a followup idea prior to the bell yesterday that yielded big-time profit chances as well. As you can see from the screen capture below, we mentioned the possibility of rolling strike prices up to the $189.50-193.50 range, and all of those contracts were winners as well.

To give an idea of the gains available in that range, the $189.50’s made a move from 2.14-3.99 (+86%), while at the upper end, the $193.50 Calls made a 326% rip from .23-.98. All in all, there was no way to go wrong with any of our SPY Calls as the overall markets solidified their first three-day rally of 2016.

*Participation in our daily trader’s chats which currently take place via Skype is fun, free, and as simple as sending a contact request to username ‘stocksumo‘. All of our loyal readers are encouraged to take part!

Catalyst Pharmaceuticals, Inc. CPRX

We’ve spotted what could turn out to be a solid rebound play in CPRX this morning. On the heels of the company’s announcement that the FDA had served it with a letter of refusal pertaining to a recent NDA filing, the stock absolutely tanked.

The caveat is, the notice came with assurance that it was not related to the clinical data or perceived efficacy of the drug in question, but a filing error only. This means that the stock lost a good portion of its value in a single day for what seems to amount to nothing more than a clerical error (see chart below). We’ll be very interested to monitor the stock in coming sessions and observe its reaction.

Extended Watchlist:
BRCD, GLUU, RUN, EPXY, ECPN, FILM, NUUU, NWPN,

ARIA, CAMT, MACK, ECPN & Extended Watchlist

ARIAD Pharmaceuticals, Inc.  ARIA

Lately, our scans have  certainly been yielding some profitable plays, and after appearing both in Friday’s extended watchlist and yesterday morning’s report, ARIA claimed its place as the next big winner to add to that list. As we approach Thursday’s holiday hiatus, we are expecting market activity to taper as people begin to travel to their holiday destinations and generally prepare for upcoming festivities. We may decide to suspend Wednesday’s newsletter, barring some unforeseen development that may need relaying.

But for now, let’s talk about the big day ARIA had for us yesterday. After opening at 4.06, the stock came back to a low of 3.92  before running up to close at 5.13. The Northerly movement continued post-market, and the stock is gapping up this morning, so we don’t want to let ARIA slip from our radars now. Remember, this stock was trading as high as the 17.00-range as recently as last month, so it still may have some ground to recover.

So far, from Friday’s low of 3.30, the bounce on ARIA has afforded us the opportunity to make up to 55% profit (at yesterday’s closing price) and we suspect that figure could continue to grow today.

Camtek Ltd.  CAMT

CAMT came off of yesterday’s extended watchlist after it had been gapping up in premarket trading, and continued to roll throughout the day. We witnessed a move from 4.11 to a high of 5.29 on 58x the 3mo. average volume, qualifying this as a serious momentum play.

It appears CAMT will gap up once again (currently trading above 6.00) so we have our eyes peeled for continued upward activity today.

Merrimack Pharmaceuticals, Inc. MACK

On November 8th, MACK appeared in our daily report, at which time we mentioned a “big gap on the chart between the 3.00-3.40 level” that would bring us excessive gains if filled. We went on to mention the key point to watch for was a break of the 3.00 mark, and we did in fact witness that event this past Friday.

The move we were watching for did come to fruition, and the party may not be over yet; the stock is currently trading in the 3.50-range, so we will be very interested to see what happens today. We’d like to see MACK hold support at the 50DMA of 3.26 in order for it to have a good chance to pile on some added gains.

El Capitan Precious Metals, Inc. ECPN

ECPN hit our scanners today as a stock coming off of a recent consolidation that followed a big run on the chart. In early October it ran off of its 52-wk low (.055) and would subsequently hit .41 (Nov 13th) before pulling back to find support at .1142 last Thursday. Since that time it has been logging higher lows and higher highs, so we’d like to see a continuation of that trend which could make ECPN fall under the category of a solid recovery play.

We prepped a video chart on ECPN, click below and take a look:

Extended Watchlist:
ECTE, IMUC, ONVO, MBIS, OTIV, ICLD, BLRX